Abstract
Background Human wellbeing has been linked with lifestyle factors such as physical activity, diet balance, sleep quality, depression, and anxiety. However, few studies illustrate the relationship between such lifestyle factors and HPV infection. In this study, we demonstrate that lifestyle factors might be crucial for reducing the burden of cervical cancer or HPV-related cancer.
Participants and Methods Participants were recruited through a digital eHealth platform without vaccination from May 2020 to August 2021. Both lifestyle factors and cervicovaginal mucus (CVM) samples to test for HPV outcomes were collected from each participant. In addition, the eHealth platform recorded age and gynecological diseases, which were adjusted to apply for both univariable and multivariable logistic regression. Furthermore, lifestyle factors and HPV serotype were categorized as low, intermediate, and high risk in order to conduct stratification analysis. Finally, lifestyle factors were studied in connection with sole and multiple HPV serotypes.
Results We recruited 149 HPV positive and 346 HPV negative through HPV detection. Physical activity and diet balance were significantly associated with HPV infection in lifestyle factors (P-values < 0.001) after adjusting for age and gynecological diseases. However, stratified analysis showed three factors were insignificant for HPV infection – namely, sleep quality, depression, and anxiety. Most HPV infections involved a sole HPV serotype (83%), and diet balance was the most significant difference between sole and multiple HPV infections.
Conclusions Among lifestyle factors, low physical activity or low diet balance can significantly increase HPV infection. In particular, diet balance might be related to the number of HPV serotypes. Our results suggest that exercising and regulating one’s diet may reduce the burden of HPV-related cancer.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Beijing Sport University gave HPV Infection study (ID: 2021094H) approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
